semaglutide by novo nordisk Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes Novo Nordisk shares slide after

10.2337/diabetes.53.9.2492 56

This therapy is a safe, drug-free option that can reduce inflammation, provide pain relief, and stimulate healing for a variety of common foot problems

2022), and liver fibrosis (Park et al

By tracking patients for nearly a year and a half, SURMOUNT-5 demonstrated that the Tirzepatide advantage persists through the typical weight loss trajectory and into the maintenance phase

doi: 10.1161/CIRCULATIONAHA.112.132159 146 DingCRoseJSunTWuJChenPLinCet al

Mounjaro (tirzepatide) This medicine combines GLP-1 and GIP receptor activity, which may lead to greater weight loss than semaglutide alone